Tekla Healthcare Investor... (HQH)
undefined
undefined%
At close: undefined
16.55
0.00%
After-hours Jan 03, 2025, 04:00 PM EST

Company Description

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC.

The fund invests in public equity markets across the globe.

It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.

The fund primarily invests in growth stocks of small cap companies.

It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio.

The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index.

It was previously known as H&Q Healthcare Investors.

Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Tekla Healthcare Investors
Tekla Healthcare Investors logo
Country United States
IPO Date Apr 23, 1987
Industry Asset Management
Sector Financial Services
Employees n/a
CEO Dr. Daniel R. Omstead M.S, Ph.D.

Contact Details

Address:
100 Federal Street
Boston, Massachusetts
United States
Website https://www.teklacap.com/hqh.html

Stock Details

Ticker Symbol HQH
Exchange NYSE
Fiscal Year October - September
Reporting Currency USD
CIK Code 0000805267
CUSIP Number 87911J103
ISIN Number US87911J1034
Employer ID 04-6564285
SIC Code

Key Executives

Name Position
Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager

Latest SEC Filings

Date Type Title
Dec 20, 2024 3 Filing
Dec 20, 2024 3 Filing
Dec 16, 2024 N-CEN Filing
Dec 09, 2024 N-CSR Filing
Nov 27, 2024 NPORT-P Filing
Nov 18, 2024 SC 13D/A [Amend] Filing
Oct 22, 2024 SC 13D/A [Amend] Filing
Sep 03, 2024 N-PX Filing
Aug 28, 2024 NPORT-P Filing
Aug 15, 2024 40-17G Filing